全文获取类型
收费全文 | 571944篇 |
免费 | 52559篇 |
国内免费 | 29936篇 |
专业分类
耳鼻咽喉 | 5798篇 |
儿科学 | 10587篇 |
妇产科学 | 5645篇 |
基础医学 | 42878篇 |
口腔科学 | 11102篇 |
临床医学 | 65127篇 |
内科学 | 62540篇 |
皮肤病学 | 6969篇 |
神经病学 | 21119篇 |
特种医学 | 22584篇 |
外国民族医学 | 40篇 |
外科学 | 56110篇 |
综合类 | 131255篇 |
现状与发展 | 110篇 |
一般理论 | 54篇 |
预防医学 | 59509篇 |
眼科学 | 7778篇 |
药学 | 65029篇 |
768篇 | |
中国医学 | 49534篇 |
肿瘤学 | 29903篇 |
出版年
2024年 | 2523篇 |
2023年 | 6627篇 |
2022年 | 16934篇 |
2021年 | 21532篇 |
2020年 | 17992篇 |
2019年 | 11208篇 |
2018年 | 12409篇 |
2017年 | 15093篇 |
2016年 | 11924篇 |
2015年 | 20805篇 |
2014年 | 26502篇 |
2013年 | 33532篇 |
2012年 | 48565篇 |
2011年 | 51029篇 |
2010年 | 43958篇 |
2009年 | 38966篇 |
2008年 | 42222篇 |
2007年 | 41577篇 |
2006年 | 36715篇 |
2005年 | 29906篇 |
2004年 | 22413篇 |
2003年 | 19287篇 |
2002年 | 16025篇 |
2001年 | 14220篇 |
2000年 | 11826篇 |
1999年 | 6583篇 |
1998年 | 2305篇 |
1997年 | 2040篇 |
1996年 | 1800篇 |
1995年 | 1604篇 |
1994年 | 1466篇 |
1993年 | 1178篇 |
1992年 | 2294篇 |
1991年 | 2207篇 |
1990年 | 1863篇 |
1989年 | 1744篇 |
1988年 | 1595篇 |
1987年 | 1448篇 |
1986年 | 1428篇 |
1985年 | 1212篇 |
1984年 | 864篇 |
1983年 | 823篇 |
1982年 | 525篇 |
1981年 | 436篇 |
1979年 | 609篇 |
1978年 | 437篇 |
1975年 | 438篇 |
1974年 | 498篇 |
1973年 | 477篇 |
1972年 | 428篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
目的分析托珠单抗的安全性风险,为临床合理用药提供参考。方法对世界卫生组织药品不良反应监测数据库、我国药品不良反应监测数据库、国内文献数据库中的不良反应报告情况及国外药监机构风险控制措施等相关资料进行整理与分析。结果应重视托珠单抗临床使用中可能发生的肝功能异常、皮肤损害、过敏反应、胃肠道损害、感染、血液系统损害等不良反应。结论托珠单抗临床使用中,应加强对严重感染及肝功能损害等严重不良反应的安全性监测,促进药品的临床合理使用。 相似文献
6.
7.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献8.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献9.
10.
目的分析2014-2018年黄山市淋病的流行特征,为全市的淋病防控工作提供科学依据。方法通过中国疾病预防控制信息系统收集黄山市2014—2018年的淋病数据、人口数据,进行统计分析。结果2014—2018年黄山市累计报告淋病病例761例,年均发病率为11.09/10万,年均增长率为29.14%,发病率呈逐年上升趋势(χ^2趋势=112.29,P<0.05)。淋病的人群分布中,男女报告病例数之比为13.63:1,男女发病率有统计学差异(χ^2=113.18,P<0.05);15~49岁年龄组病例数最多,占85.94%,职业以农民最多,占44.81%;以屯溪区、歙县报告病例数较多,分别占37.45%、23.26%。结论2014—2018年黄山市淋病发病率呈上升趋势,淋病防控形势严峻,需进一步完善各项防控措施。 相似文献